Weekly Recap | Abbott Laboratories -5.89%, most brokers rate it buyWeekly Review·Sep 12 at 07:39 AMABT+0.32%
Weekly Recap | Abbott Laboratories -3.68%, most brokers rate it buyWeekly Review·Sep 5 at 05:59 AMABT+0.32%
Weekly Recap | Abbott Laboratories -3.58%, dual-sensing device wins FDA nodWeekly Review·Aug 29 at 05:10 AMABT+0.32%
Weekly Recap | Abbott Laboratories +4.84%, settlement rally drives outperformanceWeekly Review·Aug 22 at 04:31 AMABT+0.32%
